ARTICLE
23 August 2019

California Introducing Regulations On CRISPER Gene Editing Products

S
STA Law Firm

Contributor

STA Law Firm logo
STA is a full practice law firm headquartered in Dubai with offices across UAE (Abu Dhabi, Dubai, Sharjah and Ras Al Khaimah) and overseas (Bahrain, Delhi, Doha, Luxembourg, Moscow, Portugal and Mumbai). We work alongside several groups of companies within the Oil and Gas, Maritime, Logistics, Real estate, Construction, Hospitality and Healthcare sectors in the region and internationally providing them with our signature bespoke and cogent legal advice. We successfully represent our clients at various courts and arbitration centers across the UAE. We are also approached by several investors internationally who wish to find suitable business partners in the region.
Gene editing is a technology and development that has arisen primarily in recent years. It is a topic that is still to this day surrounded by controversy and many ethical question and concerns.
United States Food, Drugs, Healthcare, Life Sciences

Introduction

Gene editing is a technology and development that has arisen primarily in recent years. It is a topic that is still to this day surrounded by controversy and many ethical question and concerns. However, progress has continuously occurred with countries such as China making significant though often highly controversial progress.

CRISPR is arguably the most well-known and prominent forms of Gene editing technology that is studied. It has even begun to make it into more mainstream and public products. These products are often limited to small harmless experiment kits which ordinary people can purchase. They usually allow for experimentation with bacteria.

With the entire concept being reasonably new, the legal systems in place around the world are somewhat limited to non-existent. This issue is especially real when it comes to products that utilise these technologies. California has recently decided to implement a new regulation on this topic, which is summarised as follows.

Appropriate Labelling

Products which utilise CRISPR technology are becoming more prominent, though the packaging and warning are not specified under the law. California is the first state in the US to introduce regulations such as these.

The regulations will require warnings to be placed on the products telling customers not to use them on humans. There should be clear labelling stating self-administration is not safe. This labelling is for the protection of the general public as significant health issues may arise with product mistreatment.

These types of warning are nothing surprising and very much expected. The only reason they have not arisen as of yet is due to the recent introduction of such products.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More